This result seems to be in opposition to the observation made by Chien et al. who demonstrated that a decreased level of Bcl-XL expression is associated with enhanced Bel-sensitivity of BxPc3 and AsPc1 pancreatic cancer cell lines [24]. This evidence concerns the gene BCL2L1 and familial pancreatic carcinoma.